scPharmaceuticals Inc. Files 8-K on Financials

Scpharmaceuticals Inc. 8-K Filing Summary
FieldDetail
CompanyScpharmaceuticals Inc.
Form Type8-K
Filed DateMar 19, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, sec-filing

Related Tickers: SCPH

TL;DR

SCPH filed an 8-K on 3/19/25 for financial updates.

AI Summary

On March 19, 2025, scPharmaceuticals Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or significant events were detailed in the provided excerpt.

Why It Matters

This 8-K filing indicates scPharmaceuticals Inc. is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific financial results or material events that would indicate a high or medium risk.

Key Players & Entities

  • scPharmaceuticals Inc. (company) — Registrant
  • 0001193125-25-057823 (other) — Accession Number
  • March 19, 2025 (date) — Report Date
  • 25 Burlington Mall Road, Suite 203 (address) — Principal Executive Offices
  • Burlington, Massachusetts (location) — Principal Executive Offices Location
  • 01803 (zip_code) — Principal Executive Offices Zip Code
  • 617-517-0730 (phone_number) — Registrant's telephone number

FAQ

What is the primary purpose of this 8-K filing by scPharmaceuticals Inc.?

The primary purpose of this 8-K filing is to report on the company's Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.

On what date was this 8-K report filed?

This 8-K report was filed on March 19, 2025.

What is the principal executive office address for scPharmaceuticals Inc.?

The principal executive office address for scPharmaceuticals Inc. is 25 Mall Road, Suite 203, Burlington, Massachusetts 01803.

What is the telephone number listed for scPharmaceuticals Inc.?

The telephone number listed for scPharmaceuticals Inc. is (617) 517-0730.

What is the Standard Industrial Classification (SIC) code for scPharmaceuticals Inc.?

The Standard Industrial Classification (SIC) code for scPharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding scPharmaceuticals Inc..

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.